AbbVie Inc. (ABBV)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
| Previous Close | 152.34 |
| Open | 153.00 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1000 |
| Day's Range | 152.75 - 155.45 |
| 52 Week Range | 105.56 - 175.91 |
| Volume | |
| Avg. Volume | 7,352,337 |
| Market Cap | 270.615B |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | 21.97 |
| EPS (TTM) | 6.97 |
| Earnings Date | Jul 28, 2022 - Aug 01, 2022 |
| Forward Dividend & Yield | 5.64 (4.08%) |
| Ex-Dividend Date | Apr 14, 2022 |
| 1y Target Est | 163.01 |
- Zacks
AbbVie (ABBV) Gains As Market Dips: What You Should Know
In the latest trading session, AbbVie (ABBV) closed at $153.14, marking a +0.53% move from the previous day.
- Zacks
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
The CHMP recommends approval of AbbVie's (ABBV) Rinvoq for treating adults with active non-radiographic axial spondyloarthritis.
- Motley Fool
Is AbbVie About To Get A New Blockbuster Drug?
AbbVie recently applied for FDA approval of its advanced Parkinson's disease drug candidate. This could be huge considering it's set to lose market exclusivity of Humira.
© 2022 Yahoo. All rights reserved.
